abstract |
The present invention relates to a pharmaceutical composition comprising (a) as the active ingredient, rasagiline in the form of pharmaceutically acceptable salt, (b) diluent, (c) lubricant and/or glidant and optionally (d) disintegrant, (e) binder, wherein the composition is not prepared by wet granulation process. The composition is preferably prepared by direct compression. |